John Young

Johnson Controls, Inc. operates as a global diversified technology and industrial business. The firm operates through the following segments: Building Efficiency, Automotive Experience and Power Solutions. The Building Efficiency segment engages in designing, producing, marketing and installing integrated heating, ventilating and air conditioning systems, building management systems, controls, security and mechanical equipment. The Automotive Experience segment provides innovative interior systems through its design and engineering expertise. The Power Solutions segment is a global supplier of lead-acid automotive batteries for passenger car, light truck and utility vehicle. It serves both automotive original equipment manufacturers and the general vehicle battery aftermarket. It also supplies batteries to power Start-Stop vehicles, as well as lithium-ion battery technologies to power certain hybrid and electric vehicles. The company was founded by Warren Seymour Johnson and William Plankinton in 1885 and is headquartered in Milwaukee, WI.

Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA.